Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Allscripts Healthcare Solutions, Inc. (MDRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.23-0.07 (-0.46%)
At close: 04:00PM EDT
15.23 0.00 (0.00%)
After hours: 04:49PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.30
Open15.34
Bid14.94 x 3000
Ask15.90 x 3200
Day's Range15.21 - 15.57
52 Week Range13.10 - 23.25
Volume1,386,027
Avg. Volume1,309,204
Market Cap1.867B
Beta (5Y Monthly)1.03
PE Ratio (TTM)3.21
EPS (TTM)4.75
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 07, 2008
1y Target Est22.00
  • Business Wire

    Allscripts to Host Virtual Investor Day September 28th

    CHICAGO, September 19, 2022--Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will host a virtual Investor Day on Wednesday, September 28, 2022 at 12:00 p.m. (Eastern). The event will include presentations made by members of the executive management team followed by a question-and-answer session. Participants may access the virtual conference by registering with our webcast registration or dial-in registration (for Q&A) links. Presentation slides will be posted on the day of the event, at ap

  • Business Wire

    Veradigm and Vytalize Health: Paving the Way for Primary Care Physicians to Improve Patient Outcomes

    CHICAGO, September 14, 2022--Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and Vytalize Health, a new kind of Medicare ACO focused on helping primary care doctors manage their Medicare patients, announced today a new agreement for Vytalize Health to integrate its solutions and services directly into the Practice Fusion EHR, a Veradigm Network solution.

  • Zacks

    Here's Why You Should Hold on to Allscripts (MDRX) Stock Now

    Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.

Advertisement
Advertisement